Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy

Table 2 The protocols of remdesivir (29 facilities responded)

Methods	Duration	Number (%)**
Administration by the normal dose*	5 days	6 (20.7)
	6–9 days	6 (20.7)
	10 days	2 (6.9)
	Not shown	2 (6.9)
Administration 4 h before dialysis	5–6 times	4 (13.8)
Administration 4 h before dialysis	Not shown	4 (13.8)
Others		5 (17.2)

^*Usual daily dose: day 1, 200 mg; day 2 onwards, 100 mg
^**Percentage for the facilities providing remdesivir protocol (29 facilities)
Other dosage methods
-100 mg three times after dialysis
-100 mg on consecutive days (specific duration is not shown)
-100 mg (day 1), 50 mg (days 2–5)
-200 mg (day 1), 100 mg (days 2 and 3), dialysis thereafter for a total of 10 vials
-200 mg (day 1), 100 mg (days 2 and 3), dialysis thereafter
Perform 3 h of CHDF 4 h after administration

ISSN: 2059-1381